The future of healthcare is being reshaped and RWE is playing an increasing role in revolutionizing patient care, drug development, and healthcare policy. Transformational developments in the industry are emerging and impacting 2024 planning: new legislations and regulations including the Inflation Reduction Act in the US, Generative AI and new technologies creating new opportunities and ways of working, and ever-evolving and diverse patient needs.

Join our virtual conference to recognize opportunities and unlock the full potential of RWE in 2024 by:

• Understanding diverse perspectives from bio-pharmaceutical members on recent trends, opportunities and challenges in 2024
• Recognizing the current status of Generative AI alongside a wide range of future developments from simple chatbots, to predictive analytics and foundational models
• Understanding strategic considerations following the Inflation Reduction Act implementation, and its implications abroad
• Innovative approaches including mosaic and enriched studies to maximize use of heterogenous data in APAC, and external comparators used alongside clinical trial data
• Increased patient adherence and outcomes through Patient Support Programs in Japan